 State Street Corp increased its position in shares of CymaBay Therapeutics Inc NASDAQ:CBAY by 0.8 in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,421,566 shares of the biopharmaceutical companys stock after purchasing an additional 11,652 shares during the period. State Street ... 